SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
ZIOPHARM +4% after ASCO presentation
ZIOPHARM Oncology (NASDAQ:ZIOP) pushes higher after presenting data on the treatment of recurrent glioblastoma as part of the ASCO Virtual Scientific Progr
seekingalpha · 6d ago
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 American Society of Clinical Oncology
GlobeNewswire · 6d ago
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28)
Benzinga · 6d ago
Ziopharm Oncology Announces Management Transition
GlobeNewswire · 05/27 21:15
Ziopharm Oncology to Present at the Jefferies 2020 Healthcare Conference on June 3, 2020 
BOSTON, May 27, 2020 -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to.
GlobeNewswire · 05/27 12:30
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Benzinga · 05/24 18:40
Here's Why We're Not Too Worried About ZIOPHARM Oncology's (NASDAQ:ZIOP) Cash Burn Situation
Simply Wall St. · 05/11 19:50
HC Wainwright & Co. Reiterates Buy on ZIOPHARM Oncology, Lowers Price Target to $5.5
HC Wainwright & Co. reiterates ZIOPHARM Oncology (NASDAQ:ZIOP) with a Buy and lowers the price target from $6.5 to $5.5.
Benzinga · 05/11 11:22
Edited Transcript of ZIOP earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/08 21:01
Ziopharm Oncology Inc (ZIOP) Q1 2020 Earnings Call Transcript
Motley Fool · 05/08 21:00
Ziopharm Oncology to Present at the BofA Securities 2020 Health Care Conference
GlobeNewswire · 05/08 14:00
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/08 03:06
ZIOPHARM Oncology EPS in-line
ZIOPHARM Oncology (NASDAQ:ZIOP): Q1 GAAP EPS of -$0.09 in-line. Cash and cash equivalents of $171M Press Release
seekingalpha · 05/08 01:15
Ziopharm Oncology Reports First Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire · 05/07 21:05
ZIOPHARM Oncology Q1 EPS $(0.090) Beats $(0.630) Estimate
ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.090) per share which beat the analyst consensus estimate of $(0.630) by 85.71 percent. This is a 12.5 percent decrease over losses of $(0.080) per share
Benzinga · 05/07 20:27
ZIOPHARM Oncology Q1 Earnings Preview
ZIOPHARM Oncology (NASDAQ:ZIOP) is scheduled to announce Q1 earnings results on Thursday, May 7th, after market close. The consensus EPS Estimate is -$0.09
seekingalpha · 05/07 02:35
Ziopharm Oncology Announces Poster Presentations at the 2020 American Society of Clinical Oncology Virtual Meeting
GlobeNewswire · 04/30 13:00
Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020
BOSTON, April 27, 2020 -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced the Company will host a conference call and webcast on Thursday, May 7, at 4:30 pm EDT to.
GlobeNewswire · 04/27 12:30
Ziopharm- Catalysts in T-Cell Therapy
MoneyShow · 04/06 11:00
Benzinga's Top Upgrades, Downgrades For March 4, 2020
Benzinga · 03/04 15:08